Re (RMAX) EBIT (2012 - 2026)

Re (RMAX) has 15 years of EBIT data on file, last reported at -$7.8 million in Q1 2026.

• EBIT for Q1 2026 came in at -$7.8 million, down 245.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.9 million (down 17.48% YoY), and the FY2025 annual result was $47.0 million, up 17.08% from the prior year.
• EBIT fell to -$7.8 million in Q1 2026 per RMAX's latest filing, from $9.3 million in the prior quarter.
• Over five years, EBIT peaked at $18.3 million in Q3 2025 and troughed at -$21.0 million in Q3 2023.
• A 5-year average of $6.3 million and a median of $7.6 million in 2022 frame the typical range for EBIT.
• The sharpest annual moves came in 2023 and 2024: EBIT plunged 501.11% in 2023, then soared 172.44% in 2024.
• A 5-year view of EBIT shows it stood at $8.5 million in 2022, then plunged by 214.58% to -$9.7 million in 2023, then jumped by 144.03% to $4.3 million in 2024, then jumped by 118.17% to $9.3 million in 2025, then slumped by 183.97% to -$7.8 million in 2026.
• Business Quant data shows RMAX's EBIT at -$7.8 million in Q1 2026, $9.3 million in Q4 2025, and $18.3 million in Q3 2025.